Trazodone for depression and insomnia with poor sleep quality
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if trazodone, a medication, can improve deep sleep in people who have both depression and insomnia. It aims to find a treatment that helps with both conditions at once.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with both depression and insomnia by a doctor.
- Your depression is moderate to severe (score of 17 or more on a standard depression scale).
- You have poor sleep quality (score of 16 or more on a standard sleep scale).
- You have never taken antidepressants or sleeping pills for this condition.
- You can read and understand simple instructions and fill out questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding mianserin to an SSRI (a common antidepressant) can improve depression in people whose main problem also includes sleep trouble. It may help by targeting both mood symptoms and difficulty sleeping.
This study tests whether trazodone, a sleep medication, improves insomnia in people 65 and older. You might benefit if you struggle with falling or staying asleep and are not already taking other sleep aids.
This trial tests whether cognitive behavioral therapy (a type of talk therapy for sleep) and/or the medication trazodone can improve sleep and lower blood pressure in people with chronic insomnia. You must be 18 or older and have ongoing trouble sleeping.
This trial tests a combination of two behavioral therapies to improve both depression symptoms and sleep problems. It may help you if you have moderate depression and insomnia and can participate in French-language sessions.
This study tests how well the antidepressant trazodone works in older adults with major depression and mild cognitive impairment (early memory or thinking problems). It looks at real-world results in people starting this treatment.
This trial tests if taking psilocybin (a psychedelic drug) with trazodone (an antidepressant) can help people whose depression hasn't improved with at least two standard antidepressants. If you have treatment-resistant depression, this study might be an option.
Hear when a new Depressed Insomniac Co-morbid Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.